175 related articles for article (PubMed ID: 19112224)
21. Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.
Cernigliaro JG; Haley WE; Adolphson DP; Jepperson MA; Crook JE; Thomas CS; Parker AS
Clin Imaging; 2016; 40(5):902-6. PubMed ID: 27183138
[TBL] [Abstract][Full Text] [Related]
22. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
Ladwig M; Flemming B; Seeliger E; Sargsyan L; Persson PB
Invest Radiol; 2011 Nov; 46(11):672-7. PubMed ID: 21623210
[TBL] [Abstract][Full Text] [Related]
23. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
[TBL] [Abstract][Full Text] [Related]
24. Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT.
Zo'o M; Hoermann M; Balassy C; Brunelle F; Azoulay R; Pariente D; Panuel M; Le Dosseur P
Pediatr Radiol; 2011 Nov; 41(11):1393-400. PubMed ID: 21713440
[TBL] [Abstract][Full Text] [Related]
25. Contrast-agent-induced acute renal dysfunction--is iodixanol the answer?
Sandler CM
N Engl J Med; 2003 Feb; 348(6):551-3. PubMed ID: 12571263
[No Abstract] [Full Text] [Related]
26. Microvascular resistance in response to iodinated contrast media in normal and functionally impaired kidneys.
Kurihara O; Takano M; Uchiyama S; Fukuizumi I; Shimura T; Matsushita M; Komiyama H; Inami T; Murakami D; Munakata R; Ohba T; Hata N; Seino Y; Shimizu W
Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1245-50. PubMed ID: 26277785
[TBL] [Abstract][Full Text] [Related]
27. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.
Heinrich MC; Häberle L; Müller V; Bautz W; Uder M
Radiology; 2009 Jan; 250(1):68-86. PubMed ID: 19092091
[TBL] [Abstract][Full Text] [Related]
28. Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats.
Jost G; Pietsch H; Sommer J; Sandner P; Lengsfeld P; Seidensticker P; Lehr S; Hütter J; Sieber MA
Invest Radiol; 2009 Feb; 44(2):114-23. PubMed ID: 19104440
[TBL] [Abstract][Full Text] [Related]
29. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
[TBL] [Abstract][Full Text] [Related]
30. Iodixanol in femoral arteriography. A randomized, double-blind, phase III, parallel study with iodixanol 270 mg I/ml and iohexol 300 mg I/ml.
Thorstensen O; Albrechtsson U; Calissendorff B; Lárusdóttir H; Norgren L; Tengvar M; Bolstad B; Aspelin P
Acta Radiol; 1994 Nov; 35(6):629-31. PubMed ID: 7946690
[TBL] [Abstract][Full Text] [Related]
31. Effects of non-ionic monomeric and dimeric iodinated contrast media on renal and systemic haemodynamics in rats.
Idée JM; Lancelot E; Berthommier C; Couturier-Goulas V; Vazin V; Corot C
Fundam Clin Pharmacol; 2000; 14(1):11-8. PubMed ID: 10681069
[TBL] [Abstract][Full Text] [Related]
32. Iodixanol in paediatric gastrointestinal imaging: safety and efficacy comparison with iohexol.
Wright NB; Carty HM; Sprigg A; Kampenes VB; Friis M; Petersen KK; Stake G; Klaveness AJ
Br J Radiol; 2002 Feb; 75(890):127-35. PubMed ID: 11893636
[TBL] [Abstract][Full Text] [Related]
33. Exposure to low- vs iso-osmolar contrast agents reduces NADPH-dependent reactive oxygen species generation in a cellular model of renal injury.
Netti GS; Prattichizzo C; Montemurno E; Simone S; Cafiero C; Rascio F; Stallone G; Ranieri E; Grandaliano G; Gesualdo L
Free Radic Biol Med; 2014 Mar; 68():35-42. PubMed ID: 24300339
[TBL] [Abstract][Full Text] [Related]
34. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
35. Elimination of the non-ionic X-ray contrast media iodixanol and iohexol in patients with severely impaired renal function.
Nossen JO; Jakobsen JA; Kjaersgaard P; Andrew E; Jacobsen PB; Berg KJ
Scand J Clin Lab Invest; 1995 Jul; 55(4):341-50. PubMed ID: 7569737
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.
McCullough PA; Bertrand ME; Brinker JA; Stacul F
J Am Coll Cardiol; 2006 Aug; 48(4):692-9. PubMed ID: 16904536
[TBL] [Abstract][Full Text] [Related]
37. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.
Biondi-Zoccai G; Lotrionte M; Thomsen HS; Romagnoli E; D'Ascenzo F; Giordano A; Frati G
Int J Cardiol; 2014 Mar; 172(2):375-80. PubMed ID: 24502883
[TBL] [Abstract][Full Text] [Related]
38. [Role of color Doppler US in the evaluation of renal transplant].
Drudi FM; Cascone F; Pretagostini R; Ricci P; Trippa F; Righi A; Iannicelli E; Passariello R
Radiol Med; 2001 Apr; 101(4):243-50. PubMed ID: 11398053
[TBL] [Abstract][Full Text] [Related]
39. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
[TBL] [Abstract][Full Text] [Related]
40. Renal safety of iodixanol.
McCullough PA
Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
